Skip to content

Clinical trials

Completed Phase 3 Diabetes Mellitus trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Status: Completed Clear all

530 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200112
200216
200330
200430
200527
200641
200734
200831
200929
201039
201134
201227
201330
201429
20158
201626
201723
20185
20196
20204
20214
20226
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed530

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S169
AstraZeneca49
Takeda32
Eli Lilly and Company22
GlaxoSmithKline11
Astellas Pharma Inc9
Sanofi9
National Heart, Lung, and Blood Institute (NHLBI)7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus530
Diabetes Mellitus, Type 2284
Diabetes Mellitus, Type 174
Glucose Metabolism Disorders34
Insulin Resistance29
Hypertension28
Dyslipidemias25
Cardiovascular Diseases18
Metabolic Diseases15
Obesity12

Trials

Showing 1 to 25 of 530. Each trial links to its page on Pharma Observatory.

430 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.